LEADING THE
FUTURE OF
GLAUCOMA
CARE
M
I
G
S
+
C
ATA
R
A
C
T
S
U
R
G
E
R
Y
I
N
T
E
R
V
E
N
T
I
O
N
A
L
G
L
A
U
C
O
M
A
M
I
G
S
+
C
ATA
R
A
C
T
S
U
R
G
E
R
Y
M
I
G
S
S
TA
N
D
A
L
O
N
E
P
R
O
C
E
D
U
R
A
L
P
H
A
R
M
A
C
E
U
T
I
C
A
L
S
Contact your local Glaukos
representative and learn more
about our IG initiative.
We'll go fi rst.
©2025 Glaukos Corporation. All rights reserved. Glaukos is a
registered trademark of Glaukos Corporation. PM-US-3089
IG=interventional glaucoma; MIGS=minimally invasive glaucoma surgery.
Glaukos is dedicated to patients
worldwide. We reinvest over 30%
of all sales back into research and
development, driving innovation that
elevates the standard of care for all
patients—today, tomorrow, and for
years to come.
